Brought to you by 
Danaher shells out $1.1bn for MDS division and Sciex JV
04 Sep 2009
Executive Summary
Danaher is buying MDS Analytical Technologies (including its Molecular Devices division) and MDS's 50/50 mass spectrometry joint venture with Life Technologies for a total of $1.1bn in cash--MDS gets $650mm (about 65% will support a share buyback program) and LT receives $450mm ($290mm will be used to repay debt).
Deal Industry
- Medical Devices
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Danaher shells out $1.1bn for MDS division and Sciex JV
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice